Epidemiology of acquired valvular heart disease, Can J Cardiol. sept, vol.30, issue.9, pp.962-70, 2014. ,
Heart valve disease in elderly, World J Cardiol. 26 févr, vol.11, issue.2, pp.71-83, 2019. ,
Burden of valvular heart diseases: a population-based study, Lancet Lond Engl. 16 sept, vol.368, issue.9540, pp.1005-1016, 2006. ,
The pathogenesis of cardiac fibrosis, Cell Mol Life Sci CMLS. févr, vol.71, issue.4, pp.549-74, 2014. ,
Potential role of fibrosis imaging in severe valvular heart disease, Heart Br Card Soc. mars, vol.101, issue.5, pp.397-407, 2015. ,
CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF, JACC Cardiovasc Imaging. oct, vol.7, issue.10, pp.991-998, 2014. ,
Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis, Circulation. 7 sept, vol.110, issue.10, pp.1263-1271, 2004. ,
Cardiac Fibrosis and Arrhythmogenesis. Compr Physiol, vol.18, pp.1009-1058, 2017. ,
Myocardial fibrosis predicts ventricular tachyarrhythmias, Trends Cardiovasc Med, vol.27, issue.5, pp.363-72, 2017. ,
Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia, Heart Br Card Soc, vol.103, issue.3, pp.204-213, 2017. ,
Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse, J Am Coll Cardiol. 21 août, vol.72, issue.8, pp.823-857, 2018. ,
, , 2017.
Guidelines for the management of valvular heart disease, Eur Heart J. 21 sept, vol.38, issue.36, pp.2739-91, 2017. ,
, , 2017.
AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, vol.20, p.135, 2014. ,
Left ventricular dysfunction after mitral valve repair--the fallacy of « normal » preoperative myocardial function, J Thorac Cardiovasc Surg. déc, vol.148, issue.6, pp.2752-60, 2014. ,
Echocardiographic prediction of left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair, J Am Coll Cardiol. 6 août, vol.42, issue.3, pp.458-63, 2003. ,
Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications, J Am Coll Cardiol, vol.24, issue.6, pp.1536-1579, 1994. ,
Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study, Eur Heart J Cardiovasc Imaging, vol.13, issue.10, pp.819-845, 2012. ,
Predicting left ventricular dysfunction after valve repair for mitral regurgitation due to leaflet prolapse: additive value of left ventricular end-systolic dimension to ejection fraction, Eur J Echocardiogr J Work Group Echocardiogr Eur Soc Cardiol. sept, vol.12, issue.9, pp.702-712, 2011. ,
Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis, J Am Coll Cardiol. 6 mai, vol.63, issue.17, pp.1778-85, 2014. ,
Advances in the understanding of the pathophysiology and management of aortic stenosis: role of novel imaging techniques, Can J Cardiol. sept, vol.30, issue.9, pp.994-1003, 2014. ,
,
, Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage, J Am Heart Assoc. 18 déc, vol.4, issue.12, 2015.
Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis, JACC Cardiovasc Imaging. févr, vol.12, issue.2, pp.283-96, 2019. ,
Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T, J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 11 juin, vol.17, p.48, 2015. ,
T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy, Eur Heart J Cardiovasc Imaging. févr, vol.16, issue.2, pp.210-216, 2015. ,
Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis, J Am Coll Cardiol. 27 févr, vol.71, issue.8, pp.860-71, 2018. ,
Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis, JACC Cardiovasc Imaging, vol.10, issue.11, pp.1320-1353, 2017. ,
The role of biomarkers in valvular heart disease: focus on natriuretic peptides, Can J Cardiol. sept, vol.30, issue.9, pp.1027-1061, 2014. ,
Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis, Heart Br Card Soc, vol.01, issue.11, pp.862-870, 2016. ,
Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair, Eur J Heart Fail. sept, vol.15, issue.9, pp.1011-1019, 2013. ,
Predictive value of global longitudinal strain in a surgical population of organic mitral regurgitation, J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. juill, vol.25, issue.7, pp.766-72, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00905345
Global longitudinal strain predicts left ventricular dysfunction after mitral valve repair, Eur Heart J Cardiovasc Imaging. janv, vol.14, issue.1, pp.69-76, 2013. ,
Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart, Magn Reson Med. juill, vol.52, issue.1, pp.141-147, 2004. ,
Guidelines on the management of valvular heart disease (version 2012), Eur Heart J, vol.33, pp.2451-96, 2012. ,
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system, Circulation. juin, vol.83, issue.6, pp.1849-65, 1991. ,
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med. 2 sept, vol.341, issue.10, pp.709-726, 1999. ,